Listing Approval. At the Closing, the Conversion Shares shall be approved for listing on the Nasdaq Stock Market, subject to the notice of issuance.
Appears in 4 contracts
Samples: Exchange Agreement (Teligent, Inc.), Exchange Agreement (Teligent, Inc.), Exchange Agreement (Teligent, Inc.)
Listing Approval. At the Closing, the Conversion Shares shall be approved for listing on the Nasdaq Stock Market, subject to the notice of issuance. No shareholder approval is required pursuant to the rules of the Nasdaq stock market in connection with the issuance of the New Notes or the Conversion Shares.
Appears in 2 contracts
Samples: Form of Exchange Agreement (Teligent, Inc.), Form of Exchange Agreement (Teligent, Inc.)
Listing Approval. At the Closing, the Conversion Shares shall be approved for listing on the Nasdaq Stock The NASDAQ Global Select Market, subject to the notice of issuance.
Appears in 1 contract
Listing Approval. At the Closing, the Conversion Shares shall be approved for listing on the Nasdaq Stock Market, subject to the notice of issuanceNASDAQ.
Appears in 1 contract
Samples: Convertible Notes Exchange Agreement (PDL Biopharma, Inc.)
